Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

NCT02897778 is registered in ClinicalTrials.gov with Syndax Pharmaceuticals as lead sponsor.

NCT NCT02897778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02897778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors
Lead sponsor
Syndax Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
August 24, 2016
Completion date
March 13, 2017
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast diseases, breast neoplasms, bronchial neoplasms, carcinoma, non-small-cell lung, digestive system neoplasms, endocrine gland neoplasms, lung diseases, lung neoplasms, neoplasms, neoplasms by histologic type, neoplasms, glandular and epithelial, renal neoplasm, respiratory tract neoplasms, solid tumors, thoracic neoplasms